SecBot SecBot
DEFA14A ·Filed Feb 26, 2026

ALZN

Alzamend Neuro, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed8mo ago SEC0001214659-26-002584
Proxy solicitation materials
Actionable Insight • Neutral

Monitor the vote on the reverse stock split. If approved, the stock may see a short-term price bump, but the company's long-term viability remains highly questionable given its tiny market cap.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
ALZN ▼ -42.79% at T+60d
NEUTRAL call -42.79% · α vs SPY -52.17% · entry $2.01 → $1.15
Entry = T+0 close
Feb 26, 2026
via day close
T+1d
0.00%
call 0.00% · α -0.06%
$2.01
settled 8mo ago
T+5d
-1.49%
call -1.49% · α +0.49%
$1.98
settled 8mo ago
T+20d
-47.76%
call -47.76% · α -40.20%
$1.05
settled 7mo ago
T+60d
-42.79%
call -42.79% · α -52.17%
$1.15
settled 5mo ago

Price Chart

Loading chart...

Executive Summary

Alzamend Neuro, Inc. (ALZN) is holding its 2026 annual shareholder meeting to vote on several key proposals, including the election of directors, ratification of auditors, approval of a new stock incentive plan, and a critical reverse stock split. The reverse stock split is likely necessary to maintain Nasdaq listing compliance, as the company's market cap is only $8M.

Key Facts

  • Annual shareholder meeting scheduled for April 17, 2026.
  • Proposals include electing 7 directors, ratifying auditors, approving a new stock incentive plan, and a reverse stock split.
  • The reverse stock split proposal (ratio of 1-for-2 to 1-for-10) is critical for Nasdaq listing compliance.
  • The company's market cap is $8M, indicating severe financial distress and a high risk of delisting without the reverse split.

Financial Impact

The reverse stock split will increase the share price but will not change the company's $8M market cap or underlying financial health.

share pricemarket caplisting status

Risk Factors

  • The company may be unable to maintain Nasdaq listing if the reverse split is not approved or fails to raise the share price sufficiently.
  • The extremely low $8M market cap suggests the company is in severe financial distress, which could lead to bankruptcy or a takeover.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001214659-26-002584
Document: 0001214659-26-002584-index-headers.html0001214659-26-002584
Document: 0001214659-26-002584-index.html0001214659-26-002584
Document: 0001214659-26-002584.txt0001214659-26-002584
3 reports for ALZN
Performance horizon
Filters
Rows
Reports for ALZN — sortable, filterable
TypeNow
Sep 29, 2026
28d ago
8-K
NEUTRAL ★ 3/10
$1.82awaiting T+20—$1.15 (−36.81%)
Aug 4, 2026
11w ago
3
NEUTRAL ★ 2/10
$1.43 $1.70▲ +18.88%▲ +19.48%$1.15 (−19.58%)
Feb 26, 2026
34w ago
DEFA14A
NEUTRAL ★ 4/10
$2.01 $1.05▼ −47.76%▼ −40.20%$1.15 (−42.79%)
Showing 3 of 3

US Market Status

Market Open — Closes in 40m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Feb 26, 2026